Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated by Analysts at Wells Fargo & Company

Wells Fargo & Company began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $28.00 price objective on the stock.

Several other equities research analysts also recently weighed in on the company. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $28.00 price target for the company. The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a research note on Monday. They issued a “neutral” rating and a $24.00 target price for the company. Finally, Piper Sandler initiated coverage on shares of Kestra Medical Technologies in a research note on Monday. They set an “overweight” rating and a $27.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $27.67.

Kestra Medical Technologies Stock Up 6.4 %

Kestra Medical Technologies stock opened at $24.92 on Monday. Kestra Medical Technologies has a 1-year low of $20.00 and a 1-year high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.